Clinical trials are a key component of high-quality care for cancer patients and enable cancer breakthroughs. Clinical trials help cancer patients access the latest innovations in cancer care, and they help advance new standards of care that can improve survival rates and quality of life for people with cancer.
Unfortunately, clinical trial participation can be difficult and unreachable for many cancer patients, who often have to take time off work, travel long distances, and incur significant costs to participate. This leads to many clinical trials being unable to enroll enough participants and increasingly is leading to more clinical trials for new treatments and therapies being conducted outside of the U.S.
ACS CAN is working to reduce barriers to clinical trial participation and increase enrollment among underrepresented groups, including rural residents, those with limited income, older adults and communities of color.
